Clinical trial
Diindolylmethane in Healthy Volunteers
NCT00392652 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00392652 |
|---|---|
| Title | Diindolylmethane in Healthy Volunteers |
| Official title | Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction Clinical Study of Nutritional-Grade, Absorption-Enhanced DIM (BR-DIM) |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy, no Evidence of Disease |
| Intervention type | Drug |
| Interventions | oral microencapsulated diindolylmethane |
| Enrollment | 14 |
| Start date | Nov 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2009 |
| First posted | Oct 26, 2006 |
| Last update posted | Dec 29, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: